<DOC>
	<DOCNO>NCT02461446</DOCNO>
	<brief_summary>The purpose study determine cross-sectional longitudinal medical , behavioral , cognitive difference PTEN ASD group , well identify cognitive , neural system , molecular biomarkers specific PTEN ASD . In addition , study create maintain biorepository link phenotypic database PTEN ASD .</brief_summary>
	<brief_title>Natural History Study Individuals With Autism Germline Heterozygous PTEN Mutations</brief_title>
	<detailed_description>Autism spectrum disorder ( ASD ) set neurodevelopmental disorder characterize social communication/interaction impairment restricted/repetitive behavior . ASD associate germline heterozygous PTEN mutation ( PTEN ASD ) genetically define sub-group , may one prevalent genetic disorder contribute ASD ( 0.5-2 % ) . The purpose research study carefully track phenotypic molecular characteristic PTEN ASD identify biomarkers intervention study . Individuals PTEN ASD ( age 3 21 ) , macrocephalic ASD without PTEN mutation ( macro-ASD ) , healthy control , individual PTEN mutation without ASD ( PTEN no-ASD ) ask participate study . Both male female ask participate . Additionally , eligible study participation , individual ' primary communicative language must English . The study involve 5 visit ( 3 site visit ) course two year . Study visit vary length 4 hour 6 hour . Study visit involve physical exam , medical history question neuropsychological assessment blood draw do laboratory study . Individuals clinically indicate MRI scan extend 15 minute part study .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Hamartoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Hamartoma Syndrome , Multiple</mesh_term>
	<mesh_term>Megalencephaly</mesh_term>
	<criteria>Individuals age 3 21 year old time consent documentation clinical diagnosis autism spectrum disorder diagnosis and/or verify PTEN mutation medical mental health professional inclusion PTEN ASD , PTEN noASD ASD macrocephaly group . Macrocephaly ( head circumference great equal 98th percentile ) inclusion ASD macrocephaly group . Youth age 317 adult age 1821 autism spectrum disorder PTEN mutation inclusion control group . Consent parent guardians adult suspect autism spectrum disorder require legal guardian adult healthy sibling individual autism spectrum disorder . Youths able ( young severely impaired participant may able provide assent ) ask provide assent . Families multiple child meet inclusion criterion permit many child participate wish . A separate consent form fill child enrol study . Primary communicative language must English Clinically significant medical disease would prohibit participation study procedure . Individuals contraindication MRI exclude MRI portion study : 1 . Cardiac pacemaker . 2 . Intracranial aneurysm clip , metallic implant external clip within 10 mm head . 3 . Implanted metallic device pump neurostimulator device . 4 . Metallic foreign material within orbit . 5 . Pregnancy . 6 . Claustrophobia . No history significant brain lesion pathology include : 1 . History large vessel stroke , brain tumor previous neurosurgery .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>germline heterozygous PTEN mutation</keyword>
	<keyword>MRI</keyword>
	<keyword>10q23.3</keyword>
	<keyword>ASD</keyword>
	<keyword>Autism</keyword>
	<keyword>Macrocephaly</keyword>
	<keyword>PTEN Hamartoma Tumor Syndrome</keyword>
	<keyword>PTEN</keyword>
</DOC>